These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Metastatic prostate cancer in a transgenic mouse. Gingrich JR; Barrios RJ; Morton RA; Boyce BF; DeMayo FJ; Finegold MJ; Angelopoulou R; Rosen JM; Greenberg NM Cancer Res; 1996 Sep; 56(18):4096-102. PubMed ID: 8797572 [TBL] [Abstract][Full Text] [Related]
25. Adenovirus-mediated CD40 ligand therapy induces tumor cell apoptosis and systemic immunity in the TRAMP-C2 mouse prostate cancer model. Dzojic H; Loskog A; Tötterman TH; Essand M Prostate; 2006 Jun; 66(8):831-8. PubMed ID: 16491482 [TBL] [Abstract][Full Text] [Related]
26. Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer. Kim S; Lee JB; Lee GK; Chang J Prostate; 2009 Jun; 69(9):938-48. PubMed ID: 19267351 [TBL] [Abstract][Full Text] [Related]
27. The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression. Caporali A; Davalli P; Astancolle S; D'Arca D; Brausi M; Bettuzzi S; Corti A Carcinogenesis; 2004 Nov; 25(11):2217-24. PubMed ID: 15358631 [TBL] [Abstract][Full Text] [Related]
28. Vasculature-targeted tumor necrosis factor-alpha increases the therapeutic index of doxorubicin against prostate cancer. Bertilaccio MT; Grioni M; Sutherland BW; Degl'Innocenti E; Freschi M; Jachetti E; Greenberg NM; Corti A; Bellone M Prostate; 2008 Jul; 68(10):1105-15. PubMed ID: 18437689 [TBL] [Abstract][Full Text] [Related]
29. Castration triggers growth of previously static androgen-independent lesions in the transgenic adenocarcinoma of the mouse prostate (TRAMP) model. Johnson MA; Iversen P; Schwier P; Corn AL; Sandusky G; Graff J; Neubauer BL Prostate; 2005 Mar; 62(4):322-38. PubMed ID: 15389779 [TBL] [Abstract][Full Text] [Related]
30. Oral grape seed extract inhibits prostate tumor growth and progression in TRAMP mice. Raina K; Singh RP; Agarwal R; Agarwal C Cancer Res; 2007 Jun; 67(12):5976-82. PubMed ID: 17575168 [TBL] [Abstract][Full Text] [Related]
31. Systemic therapy of spontaneous prostate cancer in transgenic mice with oncolytic herpes simplex viruses. Varghese S; Rabkin SD; Nielsen GP; MacGarvey U; Liu R; Martuza RL Cancer Res; 2007 Oct; 67(19):9371-9. PubMed ID: 17909046 [TBL] [Abstract][Full Text] [Related]
32. 2-Methoxyestradiol inhibits prostate tumor development in transgenic adenocarcinoma of mouse prostate: role of tumor necrosis factor-alpha-stimulated gene 6. Garcia GE; Wisniewski HG; Lucia MS; Arevalo N; Slaga TJ; Kraft SL; Strange R; Kumar AP Clin Cancer Res; 2006 Feb; 12(3 Pt 1):980-8. PubMed ID: 16467113 [TBL] [Abstract][Full Text] [Related]
33. OSU-HDAC42, a histone deacetylase inhibitor, blocks prostate tumor progression in the transgenic adenocarcinoma of the mouse prostate model. Sargeant AM; Rengel RC; Kulp SK; Klein RD; Clinton SK; Wang YC; Chen CS Cancer Res; 2008 May; 68(10):3999-4009. PubMed ID: 18483287 [TBL] [Abstract][Full Text] [Related]
34. Oral treatment of the TRAMP mice with doxazosin suppresses prostate tumor growth and metastasis. Chiang CF; Son EL; Wu GJ Prostate; 2005 Sep; 64(4):408-18. PubMed ID: 15789364 [TBL] [Abstract][Full Text] [Related]
35. Novel syngeneic pseudo-orthotopic prostate cancer model: vascular, mitotic and apoptotic responses to castration. Frost GI; Lustgarten J; Dudouet B; Nyberg L; Hartley-Asp B; Borgström P Microvasc Res; 2005 Jan; 69(1-2):1-9. PubMed ID: 15797254 [TBL] [Abstract][Full Text] [Related]
36. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model. Narayanan BA; Narayanan NK; Pittman B; Reddy BS Clin Cancer Res; 2004 Nov; 10(22):7727-37. PubMed ID: 15570007 [TBL] [Abstract][Full Text] [Related]
37. Epithelial-stromal tumor of the seminal vesicles in the transgenic adenocarcinoma mouse prostate model. Tani Y; Suttie A; Flake GP; Nyska A; Maronpot RR Vet Pathol; 2005 May; 42(3):306-14. PubMed ID: 15872376 [TBL] [Abstract][Full Text] [Related]
38. Molecular classification of green tea catechin-sensitive and green tea catechin-resistant prostate cancer in the TRAMP mice model by quantitative real-time PCR gene profiling. Scaltriti M; Belloni L; Caporali A; Davalli P; Remondini D; Rizzi F; Astancolle S; Corti A; Bettuzzi S Carcinogenesis; 2006 May; 27(5):1047-53. PubMed ID: 16314398 [TBL] [Abstract][Full Text] [Related]
39. Evidence for downregulation of calcium signaling proteins in advanced mouse adenocarcinoma. Ruddat VC; Whitman S; Klein RD; Fischer SM; Holman TR Prostate; 2005 Jul; 64(2):128-38. PubMed ID: 15666362 [TBL] [Abstract][Full Text] [Related]
40. Effects of dutasteride on prostate growth in the large probasin-large T antigen mouse model of prostate cancer. Shao TC; Li H; Ittmann M; Cunningham GR J Urol; 2007 Oct; 178(4 Pt 1):1521-7. PubMed ID: 17707058 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]